View Item 

Show simple item record

Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis

dc.contributor.authorSingal, Amit G.en_US
dc.contributor.authorVolk, Michael L.en_US
dc.contributor.authorWaljee, Akbar K.en_US
dc.contributor.authorSalgia, R.en_US
dc.contributor.authorHiggins, Peter D.R.en_US
dc.contributor.authorRogers, Mary A. M.en_US
dc.contributor.authorMarrero, Jorge A.en_US
dc.date.accessioned2010-06-01T21:46:29Z
dc.date.available2010-06-01T21:46:29Z
dc.date.issued2009-07en_US
dc.identifier.citationSINGAL, A.; VOLK, M. L.; WALJEE, A.; SALGIA, R.; HIGGINS, P.; ROGERS, M. A. M.; MARRERO, J. A. (2009). "Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis." Alimentary Pharmacology & Therapeutics 30(1): 37-47. <http://hdl.handle.net/2027.42/74816>en_US
dc.identifier.issn0269-2813en_US
dc.identifier.issn1365-2036en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/74816
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=19392863&dopt=citationen_US
dc.format.extent262339 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rightsJournal compilation © 2009 Blackwell Publishing Ltden_US
dc.titleMeta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosisen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelOtolaryngologyen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationum† Division of General Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USAen_US
dc.contributor.affiliationother* Division of Gastroenterologyen_US
dc.identifier.pmid19392863en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/74816/1/j.1365-2036.2009.04014.x.pdf
dc.identifier.doi10.1111/j.1365-2036.2009.04014.xen_US
dc.identifier.sourceAlimentary Pharmacology & Therapeuticsen_US
dc.identifier.citedreferenceBosch FX, Ribes J, Cleries R, Diaz M. Epidemiology of hepatocellular carcinoma. Clin Liver Dis 2005; 9: 191 – 211 v.en_US
dc.identifier.citedreferenceEl-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 2004; 127 ( Suppl. 1 ): S27 – 34.en_US
dc.identifier.citedreferenceEspey DK, Wu XC, Swan J, et al. Annual report to the nation on the status of cancer, 1975–2004, featuring cancer in American Indians and Alaska Natives. Cancer 2007; 110: 2119 – 52.en_US
dc.identifier.citedreferenceEl-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132: 2557 – 76.en_US
dc.identifier.citedreferenceFattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 2004; 127 ( Suppl. 1 ): S35 – 50.en_US
dc.identifier.citedreferenceCapocaccia R, Sant M, Berrino F, Simonetti A, Santi V, Trevisani F. Hepatocellular carcinoma: trends of incidence and survival in Europe and the United States at the end of the 20th century. Am J Gastroenterol 2007; 102: 1661 – 70; quiz 1660, 1671.en_US
dc.identifier.citedreferenceEl-Serag HB, Mason AC, Key C. Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States. Hepatology 2001; 33: 62 – 5.en_US
dc.identifier.citedreferenceLlovet JM, Bruix J. Early diagnosis and treatment of hepatocellular carcinoma. Baillieres Best Pract Res Clin Gastroenterol 2000; 14: 991 – 1008.en_US
dc.identifier.citedreferenceIoannou GN, Perkins JD, Carithers RL Jr. Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival. Gastroenterology 2008; 134: 1342 – 51.en_US
dc.identifier.citedreferenceMazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693 – 9.en_US
dc.identifier.citedreferenceLlovet JM, Bustamante J, Castells A, et al. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 1999; 29: 62 – 7.en_US
dc.identifier.citedreferenceMarrero JA, Fontana RJ, Barrat A, et al. Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort. Hepatology 2005; 41: 707 – 16.en_US
dc.identifier.citedreferenceMeissner HI, Smith RA, Rimer BK, et al. Promoting cancer screening: learning from experience. Cancer 2004; 101 ( Suppl. 5 ): 1107 – 17.en_US
dc.identifier.citedreferenceGupta S, Bent S, Kohlwes J. Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis. Ann Intern Med 2003; 139: 46 – 50.en_US
dc.identifier.citedreferenceColli A, Fraquelli M, Casazza G, et al. Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review. Am J Gastroenterol 2006; 101: 513 – 23.en_US
dc.identifier.citedreferenceWhiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003; 3: 25.en_US
dc.identifier.citedreferenceHiggins J, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539 – 58.en_US
dc.identifier.citedreferenceHiggins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Br Med J 2003; 327: 557 – 60.en_US
dc.identifier.citedreferenceCopas JB, Shi JQ. A sensitivity analysis for publication bias in systematic reviews. Stat Methods Med Res 2001; 10: 251 – 65.en_US
dc.identifier.citedreferenceMacaskill P, Walter SD, Irwig L. A comparison of methods to detect publication bias in meta-analysis. Stat Med 2001; 20: 641 – 54.en_US
dc.identifier.citedreferenceJones CM, Athanasiou T. Summary receiver operating characteristic curve analysis techniques in the evaluation of diagnostic tests. Ann Thorac Surg 2005; 79: 16 – 20.en_US
dc.identifier.citedreferenceRosman AS, Korsten MA. Application of summary receiver operating characteristics (sROC) analysis to diagnostic clinical testing. Adv Med Sci 2007; 52: 76 – 82.en_US
dc.identifier.citedreferenceWalter SD. Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data. Stat Med 2002; 21: 1237 – 56.en_US
dc.identifier.citedreferenceHanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 29 – 36.en_US
dc.identifier.citedreferenceKnapp G, Hartung J. Improved tests for a random effects meta-regression with a single covariate. Stat Med 2003; 22: 2693 – 710.en_US
dc.identifier.citedreferenceHiggins JP, Thompson SG. Controlling the risk of spurious findings from meta-regression. Stat Med 2004; 23: 1663 – 82.en_US
dc.identifier.citedreferenceCaturelli E, Bartolucci F, Biasini E, et al. Diagnosis of liver nodules observed in chronic liver disease patients during ultrasound screening for early detection of hepatocellular carcinoma. Am J Gastroenterol 2002; 97: 397 – 405.en_US
dc.identifier.citedreferenceArrigoni A, Andriulli A, Gindro T, Piantino P, Capussotti L, Rizzetto M. Pattern analysis of serum alpha-fetoprotein in the early diagnosis of hepatocellular carcinoma in liver cirrhosis. Int J Biol Markers 1988; 3: 172 – 6.en_US
dc.identifier.citedreferenceCottone M, Turri M, Caltagirone M, et al. Screening for hepatocellular carcinoma in patients with Child’s A cirrhosis: an 8-year prospective study by ultrasound and alphafetoprotein. J Hepatol 1994; 21: 1029 – 34.en_US
dc.identifier.citedreferenceHenrion J, Libon E, De Maeght S, et al. Surveillance for hepatocellular carcinoma: compliance and results according to the aetiology of cirrhosis in a cohort of 141 patients. Acta Gastroenterol Belg 2000; 63: 5 – 9.en_US
dc.identifier.citedreferenceOka H, Kurioka N, Kim K, et al. Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology 1990; 12: 680 – 7.en_US
dc.identifier.citedreferenceZoli M, Magalotti D, Bianchi G, Gueli C, Marchesini G, Pisi E. Efficacy of a surveillance program for early detection of hepatocellular carcinoma. Cancer 1996; 78: 977 – 85.en_US
dc.identifier.citedreferenceKobayashi K, Sugimoto T, Makino H, et al. Screening methods for early detection of hepatocellular carcinoma. Hepatology 1985; 5: 1100 – 5.en_US
dc.identifier.citedreferencePateron D, Ganne N, Trinchet JC, et al. Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis. J Hepatol 1994; 20: 65 – 71.en_US
dc.identifier.citedreferencePai M, McCulloch M, Enanoria W, Colford JM Jr. Systematic reviews of diagnostic test evaluations: what’s behind the scenes? ACP J Club 2004; 141: A11 – 3.en_US
dc.identifier.citedreferenceIrwig L, Macaskill P, Glasziou P, Fahey M. Meta-analytic methods for diagnostic test accuracy. J Clin Epidemiol 1995; 48: 119 – 30; discussion 131–2.en_US
dc.identifier.citedreferenceDi Bisceglie AM. Issues in screening and surveillance for hepatocellular carcinoma. Gastroenterology 2004; 127 ( Suppl. 1 ): S104 – 7.en_US
dc.identifier.citedreferenceBruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208 – 36.en_US
dc.identifier.citedreferenceBrenner DJ, Hall EJ. Computed tomography – an increasing source of radiation exposure. N Engl J Med 2007; 357: 2277 – 84.en_US
dc.identifier.citedreferenceMarrero JA. Screening tests for hepatocellular carcinoma. Clin Liver Dis 2005; 9: 235 – 51, vi.en_US
dc.identifier.citedreferenceMarrero JA, Su GL, Wei W, et al. Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients. Hepatology 2003; 37: 1114 – 21.en_US
dc.identifier.citedreferenceBolondi L, Sofia S, Siringo S, et al. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut 2001; 48: 251 – 9.en_US
dc.identifier.citedreferenceSangiovanni A, Del Ninno E, Fasani P, et al. Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology 2004; 126: 1005 – 14.en_US
dc.identifier.citedreferenceSangiovanni A, Prati GM, Fasani P, et al. The natural history of compensated cirrhosis due to hepatitis C virus: a 17-year cohort study of 214 patients. Hepatology 2006; 43: 1303 – 10.en_US
dc.identifier.citedreferenceTradati F, Colombo M, Mannucci PM, et al. A prospective multicenter study of hepatocellular carcinoma in italian hemophiliacs with chronic hepatitis C. The Study Group of the Association of Italian Hemophilia Centers. Blood 1998; 91: 1173 – 7.en_US
dc.identifier.citedreferenceSantagostino E, Colombo M, Rivi M, et al. A 6-month versus a 12-month surveillance for hepatocellular carcinoma in 559 hemophiliacs infected with the hepatitis C virus. Blood 2003; 102: 78 – 82.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1365-2036.2009.04014.x.pdf
Size:
256.1KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.